AstraZeneca’s US Investment, Future of Psychedelic Therapy | Bloomberg Businessweek Daily 7/29/2025July 29, 2025
Share Facebook Twitter LinkedIn Pinterest Email Michael Bapis, Vios Advisors at Rockefeller Capital Management, joins ‘Closing Bell’ to discuss why investors should stick with the tech winners from the first half of the year.